Skip to main content

Stress Urinary Incontinence PAS001 ProACT

Status: Open to Enrollment
Email us to enroll

Study details

View study details on clinicaltrials.gov.

Locations

  • Santa Barbara

Clinical trial FAQs

Information for patients and study volunteers, including frequently asked questions.

Post Approval Study of the ProACT™ Adjustable Continence Therapy for Men

Scott B Tobis, M.D.
Scott B Tobis, M.D.
Principal investigator
View profile

Email us to enroll

Related clinical trials

View all clinical trials
  • A Prospective Randomized Controlled Trial of Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System

    Status: Open to Enrollment

  • Examination of Programming with the Enterra® Therapy System (EXPEDITE) in a Double-Blinded, Randomized, Prospective Study in the Treatment of Nausea and Vomiting Symptoms Using Gastric Electrical Stimulation

    Status: Open to Enrollment

  • RE-AHFIRM (RandomizEd Study of Larsucosterol in Alcohol-associated Hepatitis to Confirm saFety and effIcacy of tReatMent)

    Status: Open to Enrollment

  • A Seamless Phase 2/3 Randomized, Open-label Study to Investigate Efficacy and Safety of Frexalimab Versus Tacrolimus in Adult Kidney Transplant Recipients

    Status: Coming Soon

  • A Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase 2 Trial Evaluating the Efficacy and Safety of Felzartamab in Recipients of Kidney Transplants With Late Isolated Microvascular Inflammation (MVI)

    Status: Open to Enrollment

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?